Aumento do Risco Cardiovascular em Mulheres com Síndrome Metabólica

Today, the metabolic syndrome (MS) epidemic turned into a public health problem. The true role of MS as a risk factor of cardiovascular disease however is not defined yet. Our objective was to describe the cardiovascular risk (CVR) in 45 women with (n=25, 51±12years) and without MS (n=20, 36±13years). BMI, abdominal circumference and systolic and diastolic blood pressure (SBP and DBP) were evaluated. The levels of fasting glucose (G) and insulin, post-prandial G (ppG), triglycerides, cholesterol, HDL and LDL were measured. Insulin sensibility was evaluated using the IRHoma method. SM was defined according to the National Cholesterol Education Program. The CVR was calculated according to the Framingham score and classified as low, medium and high. The abdominal circumference and SBP were significantly higher in SM, but there were no differences in relation to the BMI and DBP. G, Gpp and triglyceride levels were significantly higher, while the HDL was lower in MS. The number of components, CVR and the proportion of cases with medium or high risk were higher in the MS. CVR was correlated with the number of components (r=0,62), circumference (r=0,45), G (r=0,72), SBP (r= 0,59) and HDL (r=-0,31) and in the multiple regression analysis only with G and SBP (r2=0,67, p<0,007). HOMA-IR was correlated with the circumference (r=0,30, p=0,04). Abdominal circumference is a good marker of IR. The women with MS are at a higher risk of suffering cardiovascular events.We believe that primary care interventions directed to the components of the syndrome can prevent and reduce the incidence of CVR in these women.